FONTEYNE PAUL R.

AMLX

FONTEYNE PAUL R. serves as Director at Amylyx Pharmaceuticals, Inc. (AMLX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$75.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$75.0K

Companies Traded

AMLX

Active Period

Jan 2022

1 total trades

Most Recent

Buy AMLX

Jan 6, 2022 · $75.0K

FONTEYNE PAUL R.'s Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

1 · $75.0K

Sells

0 · $0.00

Total Shares Bought

3,947

Total Shares Sold

AMLX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 6, 2022	Buy	3,947	$19.00	$75.0K	0

Related Insiders

Gina Mazzariello

officer: Chief Legal Officer

AMLXSell · Feb 25, 2026

Joshua B Cohen

director, officer: Co-Chief Executive Officer

AMLXSell · Feb 4, 2026

FRATES JAMES M

officer: Chief Financial Officer

AMLXSell · Feb 4, 2026

Justin B. Klee

director, officer: Co-Chief Executive Officer

AMLXSell · Feb 4, 2026

Karen Firestone

Director

AMLXBuy · Dec 23, 2025

Camille L Bedrosian

Chief Medical Officer

AMLXSell · Dec 1, 2025

Explore More Insider Trading Data

AMLX Insider Trading Activity

View all insider trades at Amylyx Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity